Dolby Laboratories Stock Plummets to New 52-Week Low at $57.62

Dolby Laboratories, Inc. has reached a new 52-week low, trading at USD 57.62 as of March 27, 2026. This marks a significant decline for the small-cap software company, which has seen its stock price decrease by 26.65% over the past year, contrasting sharply with the S&P 500's performance of 11.87% during the same period. The company's market capitalization stands at approximately USD 5,846 million, with a price-to-earnings (P/E) ratio of 23.00. Despite a dividend yield of 2.04%, Dolby's financial metrics indicate challenges, including a low debt-to-equity ratio of -0.28 and a return on equity of 9.98%. The stock's price-to-book ratio is 2.25, suggesting it is trading at a premium compared to historical valuations. Recent financial results have shown a decline in pre-tax profit and net profit, with respective decreases of 33.05% and 31.39%. Additionally, the company's cash and equivalents have reached a low of USD 1,507.67 million. Overall, Dolby Laboratories is experiencing below-par performance both in the near term and long term, as reflected in its stock price movements and financial indicators.